Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

ESMO in collaboration with MASCC- Emerging toxicities to targeted therapies: Management strategies and future directions

Safety management of Antibody-Drug-Conjugates     

Date

09 Sep 2022

Session

ESMO in collaboration with MASCC- Emerging toxicities to targeted therapies: Management strategies and future directions

Topics

Supportive Care and Symptom Management;  Survivorship

Tumour Site

Presenters

Maryam Lustberg

Authors

M. Lustberg

Author affiliations

  • Medical Oncology Department, Yale University School of Medicine, 06520 - New Heaven/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Ines Vaz Luis

Session: ESMO in collaboration with MASCC- Emerging toxicities to targeted therapies: Management strategies and future directions

Resources:

Slides

Webcast

Conclusions

Presenter: Maryam Lustberg

Session: ESMO in collaboration with MASCC- Emerging toxicities to targeted therapies: Management strategies and future directions

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.